{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:19:22Z","timestamp":1792815562568,"version":"4.5.0"},"reference-count":57,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:p>\n                    Methadone is a mu (\u03bc) opioid receptor agonist used clinically in adults and children to manage opioid use disorder, neonatal abstinence syndrome, and acute and chronic pain. It is typically marketed as a racemic mixture of\n                    <jats:italic>R<\/jats:italic>\n                    \u2010 and\n                    <jats:italic>S<\/jats:italic>\n                    \u2010enantiomers.\n                    <jats:italic>R<\/jats:italic>\n                    \u2010methadone has 30\u2010to 50\u2010fold higher analgesic potency than\n                    <jats:italic>S<\/jats:italic>\n                    \u2010methadone, and\n                    <jats:italic>S<\/jats:italic>\n                    \u2010methadone has a greater adverse effect (prolongation) on the cardiac QTc interval. Methadone undergoes stereoselective metabolism. CYP2B6 is the primary enzyme responsible for catalyzing the metabolism of both enantiomers to the inactive metabolites,\n                    <jats:italic>S<\/jats:italic>\n                    \u2010 and\n                    <jats:italic>R<\/jats:italic>\n                    \u20102\u2010ethylidene\u20101,5\u2010dimethyl\u20103,3\u2010diphenylpyrrolidine (\n                    <jats:italic>S<\/jats:italic>\n                    \u2010 and\n                    <jats:italic>R<\/jats:italic>\n                    \u2010EDDP). Genetic variation in the\n                    <jats:italic>CYP2B6<\/jats:italic>\n                    gene has been investigated in the context of implications for methadone pharmacokinetics, dose, and clinical outcomes. Most\n                    <jats:italic>CYP2B6<\/jats:italic>\n                    variants result in diminished or loss of CYP2B6 enzyme activity, which can lead to higher plasma methadone concentrations (affecting\n                    <jats:italic>S\u2010<\/jats:italic>\n                    more than\n                    <jats:italic>R\u2010<\/jats:italic>\n                    methadone). However, the data do not consistently indicate that\n                    <jats:italic>CYP2B6<\/jats:italic>\n                    \u2010based metabolic variability has a clinically significant effect on methadone dose, efficacy, or QTc prolongation. Expert analysis of the published literature does not support a change from standard methadone prescribing based on\n                    <jats:italic>CYP2B6<\/jats:italic>\n                    genotype (updates at\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.cpicpgx.org\">www.cpicpgx.org<\/jats:ext-link>\n                    ).\n                  <\/jats:p>","DOI":"10.1002\/cpt.3338","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T01:28:11Z","timestamp":1718155691000},"page":"932-938","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Clinical Pharmacogenetics Implementation Consortium Guideline for\n                    <i>CYP2B6<\/i>\n                    Genotype and Methadone Therapy"],"prefix":"10.1002","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0737-4892","authenticated-orcid":false,"given":"Katherine M.","family":"Robinson","sequence":"first","affiliation":[{"name":"Department of Pharmacy and Therapeutics University of Pittsburgh School of Pharmacy  Pittsburgh Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4389-7447","authenticated-orcid":false,"given":"Seenae","family":"Eum","sequence":"additional","affiliation":[{"name":"Division of Pharmacology and Pharmaceutical Sciences School of Pharmacy, University of Missouri\u2010Kansas City  Kansas City Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1513-1295","authenticated-orcid":false,"given":"Zeruesenay","family":"Desta","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine Indiana University School of Medicine  Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1297-2053","authenticated-orcid":false,"given":"Rachel F.","family":"Tyndale","sequence":"additional","affiliation":[{"name":"Department of Pharmacology &amp; Toxicology, and Psychiatry The Centre for Addiction and Mental Health, University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6968-1893","authenticated-orcid":false,"given":"Andrea","family":"Gaedigk","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Toxicology &amp; Therapeutic Innovation Children's Mercy Research Institute  Kansas City Missouri USA"},{"name":"School of Medicine, University of Missouri\u2010Kansas City  Kansas City Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9461-1256","authenticated-orcid":false,"given":"Richard C.","family":"Crist","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Perelman School of Medicine, University of Pennsylvania  Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8998-2551","authenticated-orcid":false,"given":"Cyrine E.","family":"Haidar","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Pharmaceutical Sciences St. Jude Children's Research Hospital  Memphis Tennessee USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7215-7777","authenticated-orcid":false,"given":"Alan L.","family":"Myers","sequence":"additional","affiliation":[{"name":"Department of Diagnostic &amp; Biomedical Sciences The University of Texas Health Science Center  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8178-0616","authenticated-orcid":false,"given":"Caroline F.","family":"Samer","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Toxicology Geneva University Hospitals  Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4779-0380","authenticated-orcid":false,"given":"Andrew A.","family":"Somogyi","sequence":"additional","affiliation":[{"name":"Discipline of Pharmacology, Faculty of Health and Medical Sciences University of Adelaide  Adelaide South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6150-4320","authenticated-orcid":false,"given":"Pablo","family":"Zubiaur","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology Hospital Universitario de la Princesa, Instituto Te\u00f3filo Hernando, Universidad Aut\u00f3noma de Madrid (UAM), Instituto de Investigaci\u00f3n Sanitaria La Princesa (IP)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1951-6408","authenticated-orcid":false,"given":"Otito F.","family":"Iwuchukwu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences School of Pharmacy and Health Sciences, Farleigh Dickinson University  Florham Park New Jersey USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2414-9312","authenticated-orcid":false,"given":"Michelle","family":"Whirl\u2010Carrillo","sequence":"additional","affiliation":[{"name":"Department of Biomedical Data Science Stanford University  Stanford California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5527-6475","authenticated-orcid":false,"given":"Teri E.","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Biomedical Data Science Stanford University  Stanford California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5663-3793","authenticated-orcid":false,"given":"Kelly E.","family":"Caudle","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Pharmaceutical Sciences St. Jude Children's Research Hospital  Memphis Tennessee USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7550-042X","authenticated-orcid":false,"given":"Roseann S.","family":"Donnelly","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Pharmaceutical Sciences St. Jude Children's Research Hospital  Memphis Tennessee USA"},{"name":"Department of Pharmacy Practice Massachusetts College of Pharmacy and Health Sciences  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6613-922X","authenticated-orcid":false,"given":"Evan D.","family":"Kharasch","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology Duke University School of Medicine | Bermaride LLC  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"key":"e_1_2_11_1_1","unstructured":"CPIC.CPIC\u00ae guideline for methadone based on CYP2B6 genotype. <https:\/\/cpicpgx.org\/cpic\u2010guideline\u2010for\u2010methadone\u2010based\u2010on\u2010cyp2b6\u2010genotype\/> (2023) Accessed May 15 2023."},{"key":"e_1_2_11_2_1","unstructured":"PharmGKB.Gene\u2010specific information tables for CYP2B6. <https:\/\/www.pharmgkb.org\/page\/cyp2b6RefMaterials> (2023) Accessed May 15 2023."},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2321"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.133306"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2013.00024"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1477"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2000.951217717.x"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e3182918252"},{"key":"e_1_2_11_9_1","volume-title":"Federal Regulation of Methadone Treatment","author":"Rettig R.A.","year":"1995"},{"key":"e_1_2_11_10_1","first-page":"282","article-title":"Pharmacologic comparison of the optical isomers of methadon","volume":"93","author":"Scott C.C.","year":"1948","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-023-01571-4"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1977212147"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(97)13391-2"},{"key":"e_1_2_11_14_1","first-page":"1263","article-title":"Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception","volume":"274","author":"Codd E.E.","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100120"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1159\/000167043"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1112"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000905"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.033943"},{"key":"e_1_2_11_20_1","unstructured":"E14 clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for non\u2010antiarrhythmic drugs. <https:\/\/www.fda.gov\/regulatory\u2010information\/search\u2010fda\u2010guidance\u2010documents\/e14\u2010clinical\u2010evaluation\u2010qtqtc\u2010interval\u2010prolongation\u2010and\u2010proarrhythmic\u2010potential\u2010non\u2010antiarrhythmic\u20100> (2005) Accessed January 22 2024."},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.22.2469"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-6-200209170-00010"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.12.1280"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-021-03227-5"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-016-0415-2"},{"key":"e_1_2_11_26_1","article-title":"Methadone maintenance and QT\u2010interval: prevalence and risk factors\u2010is it effective to switch therapy to levomethadone?","volume":"11","author":"Santin L.","year":"2023","journal-title":"Biomedicine"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.100180"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2498"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2014.01.494"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-6-200903170-00103"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2011.610710"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.137"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.326"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.276"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1427"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2717"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e3181642938"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00974.x"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.09.012"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.08.011"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-012-2833-7"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000867"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109025"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.11.96"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2011.00349.x"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000450"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019527"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.115.067546"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15393"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12687"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12793"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1600917"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/1556-4029.12972"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2149"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.03.010"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07022-9"}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.3338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T05:50:13Z","timestamp":1730353813000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.3338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1002\/cpt.3338"],"URL":"https:\/\/doi.org\/10.1002\/cpt.3338","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,11]]},"assertion":[{"value":"2024-03-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}